Suspensions of herpes simplex virus types 1 and 2, cytomegalovirus, and parainfluenzavirus type 2 were inactivated within 24 h when treated at 37°C with 1 mg (5.05 mM) of copper-catalyzed sodium ascorbate per ml. The infectivity titer of respiratory syncytial virus was reduced substantially after 24 h but required 48 h for inactivation. Under these conditions, inactivation of these viruses was also successfully achieved with 5.68 mM catalyzed ascorbic acid. Copper (Cu21), when added with the ascorbate solution at 5 ,ug/ml (0.022 mM), exhibited a catalytic effect on the inactivation of these viruses. 
Procedures described by Chappell et al. (3) have established the use of beta-propiolactone and Tween 80-ethyl ether as standards for inactivating viral diagnostic reagents. Because of the hazards inherent in handling these chemicals, our laboratory was interested in evaluating safer and more efficient methods for inactivation of reagents.
During investigations of various chemical agents as preservatives and inactivators of viral diagnostic antigens, reference was found to the use of ascorbic acid as an antiviral product. Turner (12) reported the inactivation of vaccinia virus by ascorbic acid undergoing auto-oxidation catalyzed by copper. Similar reactions with bacterial, fungal, and viral agents were described by Ericsson and Ludbeck (4) . While examining the survival of enteroviruses in food, Salo and Cliver (11) also investigated the effect of ascorbic acid on polio-, coxsackie-, and echoviruses. Inactivation based on loss of RNA infectivity was described. Bissell et al.
(2) reported that ascorbic acid did not alter cell culture susceptibility to initial infection from Rous sarcoma virus but appeared to interfere with virus replication and infectivity.
We investigated by in vitro experiments the effects of ascorbic acid as an agent inactivating RNA and DNA viruses. The use and potency of these ascorbate-treated reagents in serologic assays were determined. (3) for use in the standardized complement fixation (CF) (9) , HA inhibition (6) , and the indirect HA (IHA) (1) tests. The bulk reagents were inactivated with the standard catalyzed ascorbate solution (1 mg/ml). The potency of these inactivated antigens was compared with the titer of the untreated antigens. The sensitivity and specificity of the antigens were compared by using positive control reference antiserum.
MATERIALS AND METHODS

RESULTS
Effect of chemicals. No significant pH changes were observed with a concentration of .1 mg of ascorbic acid per ml and with c 10 mg of sodium ascorbate per ml. Higher concentrations caused a rapid reduction in pH levels. Ascorbic acid concentrations of 5 and 10 mg/ml lowered the pH of the Improved MEM from 7.2 to between 3.8 and 4.7. When the medium was readjusted to pH 7.2, these ascorbic acid concentrations caused toxic or degenerative changes in the Vero cell monolayers, resulting in a sloughing of the tissue. The higher ascorbic acid concentrations also caused crystal deposits in the medium. No toxicity was observed with any concentrations of sodium ascorbate. The 1-mg/ml concentration of both products was free of all toxic effects and was used as the standard in all comparative studies. Vero cells pretreated with 1 and 5 mg of ascorbate per ml had no altered susceptibility to Para-2 infection.
Incubation temperatures. Virus and ascorbate concentrations. The effect of ascorbate concentration on the rate of virus inactivation was determined with Para-2 (Table 2) . Para-2 was inactivated more rapidly with the 1-mg/ml concentration than at the 5-mg/ml level. Little effect was observed at the 6-h interval, but gradual decline in infectivity was observed for both virus concentrations during the next 18 h. The time required for inactivation was proportional to the initial virus concentration. Portions of the suspension containing 8. Experimental results comparing the effectiveness of sodium ascorbate with ascorbic acid on CMV, Para-2, and RSV are presented in Table 4 . Both chemicals were catalyzed and were used at a concentration of 1 mg/ml. After incubation at 37°C for 6, 10, 18, and 24 h, the infectivity titers were compared with those of an untreated virus suspension. Incubation of the RSV suspension was extended to 48 h.
The CMV infectivity was reduced by 3.0 logs after a 6-h exposure to ascorbate-ascorbic acid and was inactivated by both chemicals after exposure to them for 10 h. Inactivation of Para-2 required between 10 and 18 h. While both chemicals were effective, catalyzed ascorbic acid inactivated the Para-2 virus more rapidly than did the catalyzed ascorbate. Inactivation of RSV occurred at a much slower rate than that observed with the other viruses. Inactivation was minimal during the first 10 h and increased by 18 h, but virus was still viable after 24 h. When treatment was extended to 48 h, inactivation was achieved. These results were replicated, Untreated control suspensions of Para-2 and RSV gave a <1.0-log decrease in infectivity titer during the 24-h incubation period, while the untreated CMV material showed a decline of 1.2 logs in titer. Suspensions of CMV and Para-2 treated for 24 h, and RSV treated for 48 h with either Cu2> or uncatalyzed ascorbate-ascorbic acid solutions demonstrated slightly reduced infectivity, as described with HSV (Table 3 ). This further confirmed the need for using catalyzed ascorbate for inactivation purposes.
Serologic assay. Bulk serologic reagents were prepared for Para-2, RSV, CMV, and HSV-1. The pools were split, and one-half of each reagent pool was inactivated with 1 mg of catalyzed ascorbate per ml at 37°C for 24 h. The infectivity and antigenic potency were compared with those of the untreated antigen. The Para-2, CMV, and HSV-1 antigens were inactivated by the treatment. An infectivity titer of <2.0 logs remained with the RSV antigen. Further treatment for 48 h was not attempted.
The serologic results are presented in Table 5 . The potency and specificity of the Para-2 CF and HA antigens and the HSV-1 and RSV CF antigens remained stable after inactivation. The CMV CF antigen gave a fourfold decrease in titer after inactivation. The Also, the use of beta-propiolactone in production quantity places the producer at a risk in the use of this carcinogenic material. The use of ascorbic acid (vitamin C) as an antiviral agent has been reported primarily as a prophylactic and therapeutic agent against the common cold. Our approach was to determine the in vitro effect of ascorbic acid on viruses in suspension, as measured by the infectivity of cell cultures. The results presented indicate that this procedure provides a method for inactivation of infectious viruses while utilizing a less hazardous chemical procedure. The procedure should be explored as a means of inactivation of other groups of viruses. The inactivated virus suspensions maintained their usefulness as diagnostic reagents. Four of the five viruses were successfully inactivated within 24 h. The infectious titer of the RSV preparation was reduced in 24 h and rendered innocuous after 48 h. The higher infectivity titer of the RSV suspension may have contributed to the additional time required for inactivation.
It has been reported that the stability of HSV and RSV infectivity is affected by changes in temperature, pH, and medium composition. Our experiments were conducted within a pH range of 7.0 to 7.2 at 37°C. Hambling (5) reported that the maximum infectivity of RSV was maintained at pH 7.5. Titrations showed that approximately only 10% of infectious RSV survived after 24 h of incubation at 37°C. The survival of our RSV controls (Table 4) surpassed this survival rate. We demonstrated a remaining infectivity of 88% after 24 h and 66% after 48 h of incubation at 37°C. The composition and pH of the suspending medium were reported by Lancz (8) and Lancz 
